期刊文献+

Raf激酶抑制蛋白和上皮型钙黏蛋白在结肠癌中的表达及临床意义 被引量:2

Expression and Clinical Significance of RKIP and E-cadherin Proteins in Colon Carcinoma
下载PDF
导出
摘要 目的观察Raf激酶抑制蛋白(RKIP)和上皮型钙黏蛋白(E-cadherin)在结肠癌旁黏膜及结肠癌中的表达,探讨二者在结肠癌发生、发展中的作用。方法应用免疫组织化学SP法检测62例结肠癌及癌旁组织中RKIP蛋白和E-cadherin蛋白的表达。结果 RKIP蛋白和E-cadherin蛋白在结肠癌组织中阳性表达率显著低于癌旁组织,差异有统计学意义(P<0.05)。RKIP蛋白在结肠癌组织中的阳性表达与淋巴结转移相关(P<0.05)。E-cadherin蛋白在结肠癌组织中的阳性表达与分化程度、Dukes分期、淋巴结转移相关(P<0.05)。RKIP蛋白与E-cadherin蛋白的表达之间呈正相关。结论 RKIP蛋白和E-cadherin蛋白与结肠癌的发生、发展有关,并且在肠癌的侵袭和转移中起重要作用。 Objective To study the protein expression of RKIP and E-cadher in adjacent colon mucosa and colon carcinoma,and to investigate their roles in the development of colon carcinoma.Methods The expression of RKIP and E-cadherin proteins were detected by immunohistochemical staining (Streptavidine-Peroxidase method)in 62 cases of colon carcinoma and 62 cases of adjacent colon mucosa.Results The rate of positive expression of RKIP and E-cadherin proteins in colon carcinoma was lower than the adjacent colon mucosa,and the difference was statistically significant (P < 0.05).The expression of RKIP protein in colon carcinoma was correlated with lymph node metastasis (P < 0.05).The expression of E-cadherin protein in colon carcinoma was correlated with cell differentiation,Dukes stages and lymph node metastasis (P < 0.05).The expressions of RKIP protein was positively correlated to that of E-cadherin protein in colon carcinoma.Conclusion RKIP and E-cadherin proteins were associated with the tumorigenesis and development of the colon carcinoma,which play important roles in invasion and metastasis of the colon carcinoma.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2014年第7期639-642,共4页 Journal of China Medical University
关键词 结肠癌 RKIP蛋白 E-CADHERIN蛋白 免疫组织化学 colon carcinoma RKIP protein E-cadherin protein immunohistochemistry
  • 相关文献

参考文献18

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [J]. CA, 2012,62( 1 ) : 10-29.
  • 2韩英,李世荣.大肠癌筛查方法和模式及现阶段我国筛查策略的思考[J].中华内科杂志,2010,49(9):731-732. 被引量:39
  • 3Jin CH, Wang AH, Chen JM, et al. Observation of curative efficacy and prognosis following combination chemotherapy with celecoxib in the treatment of advanced colon cancer[J].J Int Med Res, 2011, 39(6) :2129-2140.
  • 4Mathew J, Hines JE, Obafunwa JO, et al. CD44 is expressed in he- patocellular carcinomas showing vascular invasion [J].J Pathol, 1996,179( 1 ) :74-83.
  • 5Bernier I, Jolles P.Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain [J]. Biochim Biophys Acta, 1984,790 (2)174-181.
  • 6Yeung K, Seitz T, Li S, et al. Suppression of Raf- 1 kinase activity and MAP kinase signalling by RKIP [ J ]. Nature, 1999,401 (6749) : 173-177.
  • 7杨大运,齐战.RKIP、MMP-2与非小细胞肺癌侵袭转移的关系[J].肿瘤防治研究,2013,40(3):253-256. 被引量:4
  • 8Walker EJ, Rosenberg SA, Wands JR, et al.Role of Raf kinase in- hibitor protein in hepatocellular carcinoma [J]. For Immunopathol Dis Therap, 2011,2(2) : 195-204.
  • 9Wang J, Yang YH, Wang AQ, et al.lmmunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue [ J ]. Med Oncol, 2010,27 (2) : 219-223.
  • 10Minoo P, Zlobec I, Baker K, et al. Loss of raf- 1 kinase inhibitor pro- tein expression is associated with tumor progression and metastasis in colon cancer [J]. Am J Clin Pathol,2007,127 (5) : 820-827.

二级参考文献15

  • 1Xu YF, Yi Y, Qiu SJ, et al. PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection[J]. J Hepatol, 2010, 53 (5) : 872-9.
  • 2Lin K,Baritaki S, Militello L,et al. The role of B RAF muta- tions in melanoma and the induction of EMT via dysregulation of the NF-kappaB/Snail/RKIP/PTEN circuit[J]. Genes Canc- er,2010,1 (5) :409-20.
  • 3Minoo P,Zlobee I,Baker K,et al. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer [J]. Am J Clin Pathol,2007,127 (5) :820-7.
  • 4Fu Z, Kitagawa Y, Shen R, et al. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer[J]. Prostate, 2006,66 (3) : 248-56.
  • 5Li HZ, Gao Y, Zhao XL, et al. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer[J]. Mol Cancer Res,2009,7(6) ..832-40.
  • 6Daniele A,Zito AF, Giannelli G, et al. Expression of metallo- proteinases MMP-2 and MMP-9 in sentinel lymphnode and ser- um of patients with metastatic and non - metastatic breast cancer [J]. Anticancer Res,2010,30(9) :3521-7.
  • 7Chetty C, Lakka KS, Bhoopathi P, et al. Tissue inhibitor of metallo- proteinase 3 suppresses tumor angiogenesis in matrix metallo- proteinase 2-down-regulated lung cancer [J]. Cancer Res, 2008,68(22) :4736-45.
  • 8Canel M, Secades P, GarzOn-Arango M, et al. Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinom as via regulation of MMP 2 expression[J]. Br J Cancer, 2008,98 (7) : 1274-84.
  • 9Nishida Y,Miyamori H,Thompson EW, et al. Activation of matrix metalloproteinase-2 (MMP 2) by membrane type 1 ma- trix metalloproteinase through an artificial receptor for proM- MP-2 generates active MMP-2 [J]. Cancer Res,2008,68(21 ) : 9096-104.
  • 10Beshir AB, Ren G, Magpusao AN, et al. Raf kinase inhibitor pro- tein suppresses nuclear factor-kappaB dependent cancer cell in- vasion through negative regulation of matrix metalloproteinase expression[J]. Cancer Lett,2010,299(2) :137-49.

共引文献41

同被引文献8

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部